Actively Recruiting
A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)
Led by Merck Sharp & Dohme LLC · Updated on 2026-05-08
12
Participants Needed
1
Research Sites
5 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers want to learn about ulonivirine when given with atorvastatin and metformin in healthy people. The goal of this study is to compare the amount of atorvastatin and metformin in a person's body over time when given with and without ulonivirine.
CONDITIONS
Official Title
A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 55 years
- Body mass index (BMI) between 18.0 and 32.0 kg/m²
- Medically healthy with no clinically significant medical history, physical exam, lab profiles, vital signs, and ECG
You will not qualify if you...
- History of cancer (malignancy)
- Positive test for HIV, hepatitis B surface antigen (HBsAg), or hepatitis C virus (HCV)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Celerion ( Site 0001)
Tempe, Arizona, United States, 85283
Actively Recruiting
Research Team
T
Toll Free Number
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here